Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Piramal Re-Brands Drug Discovery Services | Contract Pharma
Breaking News

Piramal Re-Brands Drug Discovery Services

Expands into the contract discovery and development sector

Following the February 2011 acquisition of 02h, Piramal Pharma Solutions has re-branded its discovery chemistry and ADME services as Piramal Discovery Solutions. The re-branding reflects Piramal’s expansion into the contract discovery and development services. The company can now offer integrated drug discovery solutions from discovery chemistry to clinical trials.

O2h’s discovery capabilities include integrated teams of FTE-based medicinal chemistry, synthetic chemistry and in-vitro ADMET. The company is currently expanding its biology capabilities.

“The re-branding to Piramal Discovery Solutions reflects the aim of the group to be a fully integrated service provider to those that discover and develop new small molecule drugs for the treatment of disease,” said Sunil Shah, chief executive officer, Piramal Discovery Solutions. “This is also the next logical step in integration to provide robust technology transfer protocols between the nine Piramal sites around the globe as a molecule moves from early phase to later phases of development.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters